The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial

BACKGROUND: Curing locally advanced gastric cancer through surgery alone is difficult. Adjuvant and neoadjuvant chemotherapy bring potential benefits to more patients with gastric cancer based on several clinical trials. According to phase II studies and guidelines, SOX regimen as neoadjuvant chemot...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinxin, Li, Shuo, Sun, Yihong, Li, Kai, Shen, Xian, Xue, Yingwei, Liang, Pin, Li, Guoli, Chen, Luchuan, Zhao, Qun, Li, Guoxin, Fu, Weihua, Liang, Han, Xin, Hairong, Suo, Jian, Fang, Xuedong, Zheng, Zhichao, Xu, Zekuan, Chen, Huanqiu, Zhou, Yanbing, He, Yulong, Huang, Hua, Zhu, Linghua, Yang, Kun, Ji, Jiafu, Ye, Yingjiang, Zhang, Zhongtao, Li, Fei, Wang, Xin, Tian, Yantao, Park, Sungsoo, Chen, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786891/
https://www.ncbi.nlm.nih.gov/pubmed/33402102
http://dx.doi.org/10.1186/s12885-020-07764-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786891/
https://www.ncbi.nlm.nih.gov/pubmed/33402102
http://dx.doi.org/10.1186/s12885-020-07764-7

Ejemplares similares